Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PregLem SA

Division of Gedeon Richter PLC
www.preglem.com

Latest From PregLem SA

Financings Of The Fortnight: VCs Not Wowed By Single-Asset Company Model

Venture capitalists tell START-UP’s annual survey that seeing will be believing when it comes to the potential of single-asset models. Plus news on recent financings by iPierian, Evotec, ObsEva and Acacia.

Start-up ObsEva raises €25.6m, licenses Merck Serono compounds

Swiss specialty biopharma start-up ObsEva has banked a CHF32m (€25.6m) series A financing, which it plans to use to develop a batch of compounds that it has concurrently licensed from Merck Serono.

VCs Back ObsEva With $35M For Trials On Pre-term Labor Drug

The Swiss start-up will conduct a Phase II study on a compound that may reduce or prevent pre-term labor contractions, licensed from Merck Serono. It hopes to follow in the footsteps of another women's health company, PregLem, which provided exceptional returns with the same CEO and similar investors.

BioPharmaceutical Europe

Bayer Finds U.S. Not A Fertile Market For Pre-Menopausal Women’s Health

Bayer, one of the world’s largest women’s health firms, is looking East and South for growth in its women’s health franchise, shifting its attention away from mature markets in the U.S. and Europe.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Gedeon Richter PLC
  • Senior Management
  • Ksenija Pavletic Aranicki, CEO
    Jean-Pierre Nkurunziza, Fin. Dir.
    Pablo Arriagada, MD, VP, Medical Affairs
    Vilma Durante, VP, Global Mktg.
  • Contact Info
  • PregLem SA
    Phone: (41) 22 884 0350
    Route de Frontenex 41A
    Geneva, 1207
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register